-
8 A Case Series Exploring Characteristics and Outcomes of Metachronous Primary Breast and Lung Cancer in a Diverse Cohort
10 Jul 2025 23:44 GMT
… double metachronous, primary breast, and lung cancers at the Sylvester Cancer Center … this genetic subset also showing an EGFR mutation. Overall, 75% of lung tumors … early detection of lung cancer. Since double primary breast and lung cancer is rare …
-
FDA OKs New Test to Match Lung Cancer Patients With Targeted Therapies
10 Jul 2025 22:57 GMT
… or blood to identify genetic and molecular characteristics that … patients with non-small cell lung cancer (NSCLC) whose disease … cancer mutations across 46 genes.
The approval of the … mutations, a difficult-to-treat lung cancer subtype,” said Susan Chen, …
-
Welsh research aims to speed up lung cancer screening process
10 Jul 2025 17:46 GMT
… impact the diagnosis of lung cancer at an earlier stage. … for earlier diagnosis of lung cancer, improving outcomes for our … test that can detect genetic changes in circulating tumour … Currently, patients with suspected lung cancer are referred for a biopsy …
-
FDA approves Dizal’s oral therapy Zegfrovy to treat advanced lung cancer
10 Jul 2025 11:58 GMT
… subset of non-small cell lung cancer (NSCLC) patients.
The drug has … people will be diagnosed with lung cancer in the US this year … . However, a mutation in the gene coding for EGFR can lead …
-
Dr. Arjan Gower Receives Grant to Study Targeted Therapy for Early-Stage Lung Cancer
10 Jul 2025 06:29 GMT
… early-stage non-small cell lung cancer (NSCLC) with rare EGFR … improve long-term outcomes.
Lung cancer is the leading cause of … certain genetic mutations such as alterations in the EGFR gene face … care for many patients with lung cancer, but those with uncommon …
-
SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model and its catalytic activity is regulated by histone acetylation
09 Jul 2025 18:24 GMT
… deletion accelerates KRASG12C-driven lung cancer pathogenesis in vivo
Several … ablation promotes KRASG12C-driven lung tumorigenesis in vivo.
A, … of the most mutated genes in a saturation analysis … of SETD2 or homozygous genetic deletion of SETD2 promote …
-
University of Missouri scientists discover potential solution for lung cancer drug resistance
09 Jul 2025 16:43 GMT
… a major challenge in lung cancer treatment. The researchers, … for further investigations.”
Lung cancer remains the leading cause … tumors carry specific gene mutations responsive to … resistance and compensatory genes enhances lung cancer therapy” was published …
-
Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines
09 Jul 2025 12:30 GMT
… -dependent inhibition in lung cancer cells harboring KRAS … oncogenic KRAS at the genetic level, preventing the … around 30% of lung cancers. Lung cancer represents a particularly significant … SIL204 in colorectal and lung cancer applications, potential expansion …
-
Australia Launches Lung Cancer Screening Program for Smokers
09 Jul 2025 12:19 GMT
… a government-funded lung cancer screening program that provides … committee for the program.
Lung cancers that are detected early … it is probably about genetic predisposition; we don’t … members of the National Lung Cancer Screening Program Expert …
-
Oncogene Cancer Research Donates £10,425 To Support Groundbreaking Lung Cancer Research At The Institute Of Cancer Research
09 Jul 2025 06:04 GMT
… Huang Lab into oncogene-driven lung cancers.
Dr Paul Huang, … to-treat forms of lung cancer driven by genetic mutations.
“We … her diagnosis with stage 4 lung cancer. Christina, Ruth and Aude … living with oncogene-driven lung cancers. We accelerate research by …